Ionis Pharmaceuticals (NASDAQ:IONS) reported Q4 2017 earnings this Morning, coming in at $0.02 per share, beating Wall Street’s estimates of ($0.06) per Share. Revenue for the quarter came in at $172.00 million beating analyst estimates of $126.38 million Recent Insider Trading for Ionis Pharmaceuticals (NASDAQ:IONS)
- On 2/15/2018 Joseph Klein III, Director, sold 3,000 with an average share price of $48.99 per share and the total transaction amounting to $146,970.00.
- On 2/1/2018 C Frank Bennett, SVP, sold 12,500 with an average share price of $52.50 per share and the total transaction amounting to $656,250.00.
- On 1/30/2018 Joseph Klein III, Director, sold 3,000 with an average share price of $52.86 per share and the total transaction amounting to $158,580.00.
- On 1/29/2018 Patrick R O’neil, SVP, sold 355 with an average share price of $55.00 per share and the total transaction amounting to $19,525.00.
- On 1/29/2018 Stanley T Crooke, Chairman, sold 11,000 with an average share price of $54.12 per share and the total transaction amounting to $595,320.00.
- On 1/25/2018 Patrick R O’neil, SVP, sold 645 with an average share price of $55.00 per share and the total transaction amounting to $35,475.00.
Recent Trading for Ionis Pharmaceuticals (NASDAQ:IONS) Shares of Ionis Pharmaceuticals closed the previous trading session at 50.22 down -1.15 2.23% with 509409 shares trading hands.